Evidence-based assessment of pharmaceutical interventions.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
L J
LJ
Melton
D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D003362:Cost-Benefit Analysis; D015914:Estrogen Replacement Therapy; D019317:Evidence-Based Medicine; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D017048:Health Care Costs; D006620:Hip Fractures / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000517:prevention & control; D012307:Risk Factors; D016896:Treatment Outcome